易方达标普生物科技美元现汇C(012867)
动态评分： 6.13分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | NTRA | Natera Inc | 649.64 | 2.12% |
| 2024-12-31 | INSM | Insmed Inc | 638.13 | 2.09% |
| 2024-12-31 | ALNY | Alnylam Pharmaceuticals Inc | 634.99 | 2.08% |
| 2024-12-31 | REGN | 再生元制药 | 632.38 | 2.07% |
| 2024-12-31 | PCVX | Vaxcyte Inc | 616.63 | 2.02% |
| 2024-12-31 | EXAS | 精密科学 | 610.16 | 1.99% |
| 2024-12-31 | VRTX | 福泰制药 | 589.95 | 1.93% |
| 2024-12-31 | VKTX | Viking Therapeutics Inc | 557.46 | 1.82% |
| 2024-12-31 | HALO | 奥洛兹美医疗 | 528.78 | 1.73% |
| 2024-12-31 | MDGL | Madrigal Pharmaceuticals Inc | 522.37 | 1.71% |
| 2024-12-31 | TGTX | TG Therapeutics Inc | 509.64 | 1.67% |
| 2024-12-31 | ADMA | ADMA Biologics Inc | 449.59 | 1.47% |
| 2024-12-31 | ROIV | Roivant Sciences Ltd | 430.7 | 1.41% |
| 2024-12-31 | IONS | Ionis Pharmaceuticals Inc | 423.9 | 1.39% |
| 2024-12-31 | CYTK | Cytokinetics Inc | 397.11 | 1.3% |
| 2024-12-31 | BPMC | Blueprint Medicines Corp | 396.12 | 1.29% |
| 2024-12-31 | APLS | Apellis Pharmaceuticals Inc | 393.67 | 1.29% |
| 2024-12-31 | RVMD | Revolution Medicines Inc | 386.11 | 1.26% |
| 2024-12-31 | EXEL | 伊克力西斯 | 360.38 | 1.18% |
| 2024-12-31 | BBIO | BridgeBio Pharma Inc | 350.81 | 1.15% |
公告&资料
